Shares of Moderna Inc. MRNA, -4.83% slid 4.83% to $78.04 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP, +0.70% rising 0.70% to 14,533.40 and the Dow Jones Industrial Average DJIA, +0.48% rising 0.48% to 36,577.94.
The stock’s fall snapped a two-day winning streak.
Moderna Inc. closed $139.21 short of its 52-week high ($217.25), which the company achieved on December 14th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, +0.01% rose 0.01% to $155.07 and Pfizer Inc. PFE, -0.21% fell 0.21% to $28.58.
Trading volume (5.2 M) eclipsed its 50-day average volume of 4.1 M.